Eton Pharmaceuticals, Inc. SEC filings ETON
Eton Pharmaceuticals, Inc. has 421 filings in SEC EDGAR's recent list, going back to Jun 28, 2017. Its latest annual report, Form 10-K, was filed on Mar 19, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Apr 24, 2026 | Jun 9, 2026 |
| DEF 14A | Proxy statement | Apr 25, 2025 | Jun 10, 2025 |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 11, 2024 |
| DEF 14A | Proxy statement | Apr 27, 2023 | Apr 27, 2023 |
| DEF 14A | Proxy statement | Apr 28, 2022 | Apr 28, 2022 |
| DEF 14A | Proxy statement | Apr 26, 2021 | Apr 26, 2021 |
| DEFA14A | Additional proxy material | Apr 22, 2020 | — |
| DEF 14A | Proxy statement | Apr 22, 2020 | Apr 22, 2020 |
| DEFA14A | Additional proxy material | Apr 26, 2019 | — |
| DEF 14A | Proxy statement | Apr 26, 2019 | Apr 26, 2019 |
Showing 10 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ETON (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Deer Park, IL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1710340
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.